(19)
(11) EP 3 277 287 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
27.12.2023 Bulletin 2023/52

(45) Mention of the grant of the patent:
22.11.2023 Bulletin 2023/47

(21) Application number: 16771503.6

(22) Date of filing: 31.03.2016
(51) International Patent Classification (IPC): 
A61K 31/702(2006.01)
C07H 3/06(2006.01)
 C07H 1/00(2006.01)
C12P 19/18(2006.01)
(52) Cooperative Patent Classification (CPC):
C07H 1/00; C07H 3/06; C12P 19/00; C12P 19/14; C12P 19/26; A61K 31/702; A61K 31/7016; C12Y 302/01018
 
C-Sets:
A61K 31/702, A61K 2300/00;
(86) International application number:
PCT/IB2016/051823
(87) International publication number:
WO 2016/157108 (06.10.2016 Gazette 2016/40)

(54)

MIXTURES OF HUMAN MILK OLIGOSACCHARIDES COMPRISING 3 '-O-SIALYLLACTOSE

MISCHUNGEN VON HUMANEN MILCH-OLIGOSACCHARIDEN MIT 3'-O-SIALYLLACTOSE

MÉLANGE D'OLIGOSACCHARIDES DE LAIT HUMAIN COMPRENANT DU 3'-O-SIALYLLACTOSE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 31.03.2015 EP 15162014
31.03.2015 EP 15162024

(43) Date of publication of application:
07.02.2018 Bulletin 2018/06

(73) Proprietor: Glycom A/S
2970 Hørsholm (DK)

(72) Inventors:
  • CHAMPION, Elise
    31400 Toulouse (FR)
  • MCCONNELL, Bruce
    1814 La Tour de Peilz (CH)
  • DEKANY, Gyula
    Sinnamon Park, Queensland 4073 (AU)

(74) Representative: Beck Greener LLP 
Fulwood House 12 Fulwood Place
London WC1V 6HR
London WC1V 6HR (GB)


(56) References cited: : 
EP-A1- 2 522 232
WO-A1-2012/069416
WO-A1-2012/156898
WO-A1-2014/187464
US-A1- 2002 025 560
 WO-A1-2009/059996
WO-A1-2012/092153
WO-A1-2013/148134
WO-A1-2015/036138
US-A1- 2003 129 278
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).